Medindia

X

Indian Parliamentary Committee Recommends Price Margins for All Drugs

by Julia Samuel on  April 22, 2015 at 10:36 AM Drug News   - G J E 4
Price restrictions for the drugs sold in India should be on check, recommends a parliamentary committee. The law allows the National Pharmaceutical Pricing Authority (NPPA) regulator to fix prices of drugs on a list of essential medicines and keep prices in check.
Indian Parliamentary Committee Recommends Price Margins for All Drugs
Indian Parliamentary Committee Recommends Price Margins for All Drugs
Advertisement

A standing committee with a panel of 31 lawmakers on chemicals and fertiliZers, noted in a report that all medicines should be available in the market at an affordable price.

Advertisement
About 12% of the medicines sold nationwide are currently under price caps, including 348 drugs classified as essential medicines. Though the companies are allowed to hike their prices by up to 10% a year, the government regulates the prices of all other medicines.

DG Shah, Secretary general, Indian Pharmaceutical Alliance (IPA) said, "It is a part of the policy. Pharmaceutical companies don't get a chance to hike prices (more than once) a year. This price hike is linked to inflation."

All the drugs on the government's HIV/AIDS and tuberculosis control programs are likely to be added to the list of drugs subject to price caps.

Both local and foreign drug makers in India oppose the restrictions on price caps though the government earlier allowed pharmaceutical companies to hike rates of 509 essential medicines used for diabetes, hepatitis and cancer by 3.84%.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: